Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification

考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型

基本信息

  • 批准号:
    10040875
  • 负责人:
  • 金额:
    $ 15.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract This is a first submission for an NHLBI K23 Mentored Patient-Centered Career Development Award (PA-19- 119) by Christopher Knoepke, PhD, MSW, LCSW. Dr. Knoepke’s goal is to be a leading social work scientist improving the methods by which patients’ values are included as they consider advanced therapies. This proposal uses Transcatheter Aortic Valve Replacement (TAVR) as a model for studying decision support for cardiovascular disease patients generally. Candidate: Dr. Knoepke is a Licensed Clinical Social Worker who is currently an Assistant Research Professor in the Division of Cardiology at the University of Colorado School of Medicine. He has a Masters (Washington U. in St. Louis) and PhD in social work (U. of Denver). He works closely with his primary mentors (Drs. Daniel Matlock, MD, MPH & Larry Allen, MD, MHS), receiving mentorship from mentors/collaborators (including Drs. Russ Glasgow, Megan Morris, Eric Campbell, John Carroll, and Laura Scherer) through the Colorado Cardiovascular Outcomes Research Group (CCOR) & the University of Colorado’s Dissemination & Implementation Workgroup, and ACCORDS. Training/Mentors: This award augments Dr. Knoepke’s earlier training by focusing on three areas relevant to patient values in decision support:1) Advanced qualitative research; 2) clinician survey methodology; and 3) Dissemination & Implementation science. Dr. Knoepke proposes intensive mentorship; coursework & workshops, and contextual learning through the proposed research. Drs. Knoepke and Matlock have assembled a strong team of local mentors and collaborators to guide Dr. Knoepke through the training and research activities. These activities will enable Dr. Knoepke to innovatively develop decision support tools for real world care. Research: There is a pressing need to improve the science of clarifying implementing the assessment of patient values as they decide whether to accept advanced therapies. Advanced CVD patients are disproportionately offered such therapies. As advanced age & comorbidity can reduce expected benefits, the need to include patients’ values in decisions is paramount. This study will produce information relevant to clinical practice. Aim 1 will characterize the current state of practice in values clarification as it actually occurs between patients and care providers when they discuss TAVR. Aim 2 will include the development and deployment of a de novo survey of cardiology specialists, assessing design and contextual factors necessary to support dissemination of shared decision making in TAVR. Aim 3 will pragmatically pilot adapt a decision aid for older and/or high risk TAVR candidates (separately developed by Dr. Knoepke) to include findings from Aims 1 & 2. Summary: This award’s innovative collaboration between social work and cardiology will maximize implementation of findings and facilitate Dr. Knoepke’s development into a leader in improving how patient values are honored as they make complicated decisions about their health.
项目总结/摘要 这是首次提交NHLBI K23指导以患者为中心的职业发展奖(PA-19- 119)克里斯托弗Knoepke,博士,MSW,LCSW。Knoepke博士的目标是成为一名领先的社会工作科学家 改善在考虑先进疗法时纳入患者价值的方法。这 建议使用经导管主动脉瓣置换术(TAVR)作为研究决策支持的模型, 心血管疾病患者一般。候选人:Knoepke博士是一名持牌临床社会工作者, 目前是科罗拉多大学心脏病学院的助理研究教授。 药他拥有硕士学位(华盛顿大学)。在圣路易斯)和博士学位的社会工作(美国。丹佛)。他工作 密切与他的主要导师(博士丹尼尔马特洛克,医学博士,公共卫生硕士和拉里艾伦,医学博士,MHS),接收 导师/合作者(包括Russ格拉斯哥、Megan Morris、Eric坎贝尔、John 卡罗尔和劳拉谢勒)通过科罗拉多心血管结局研究组(CCOR)和 科罗拉多大学的传播和实施工作组,和ACCORDS。培训/导师:这 该奖项通过关注与患者决策价值相关的三个领域,增强了Knoepke博士早期的培训 支持:1)先进的定性研究; 2)临床医生调查方法; 3)传播和 执行科学。Knoepke博士提出了密集的指导;课程和研讨会,以及 通过所提出的研究进行情境学习。克诺普克和马特洛克博士组建了一个强大的团队 当地的导师和合作者,以指导博士Knoepke通过培训和研究活动。这些 这些活动将使Knoepke博士能够创新地开发真实的世界护理的决策支持工具。调研: 迫切需要改进科学,澄清实施患者价值评估, 他们决定是否接受先进的治疗。晚期CVD患者不成比例地被提供 这样的疗法。由于高龄和合并症会降低预期获益,因此需要将患者的 决策中的价值观至关重要。本研究将产生与临床实践相关的信息。目标1将 描述当前在价值澄清方面的实践状态,因为它实际上发生在患者和护理之间 当他们讨论TAVR时,目标2将包括制定和部署一项重新调查 心脏病学专家,评估设计和背景因素,以支持共享的传播 TAVR的决策。目标3将务实地试点调整老年和/或高风险TAVR的决策辅助工具 候选人(由Knoepke博士单独开发),包括目标1和2的发现。总结:这 社会工作和心脏病学之间的创新合作将最大限度地实现研究结果 并促进Knoepke博士发展成为改善患者价值观的领导者,因为他们 对自己的健康做出复杂的决定。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher Knoepke其他文献

Christopher Knoepke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher Knoepke', 18)}}的其他基金

Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
  • 批准号:
    10471806
  • 财政年份:
    2020
  • 资助金额:
    $ 15.45万
  • 项目类别:
Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
  • 批准号:
    10222782
  • 财政年份:
    2020
  • 资助金额:
    $ 15.45万
  • 项目类别:
Decision Support for Older and Frail Patients Considering Advanced Cardiovascular Therapies: Improving Models of Personal Values Clarification
考虑先进心血管治疗的老年和体弱患者的决策支持:改进个人价值观澄清模型
  • 批准号:
    10685586
  • 财政年份:
    2020
  • 资助金额:
    $ 15.45万
  • 项目类别:

相似海外基金

Closing Racial Disparities Through the Affordable Care Act: Medicaid Expansion, Marketplaces, Federally Qualified Community Health Centers
通过《平价医疗法案》缩小种族差异:医疗补助扩张、市场、联邦合格的社区卫生中心
  • 批准号:
    10717603
  • 财政年份:
    2023
  • 资助金额:
    $ 15.45万
  • 项目类别:
The Effects of the Affordable Care Act Medicaid Expansion on Informal Care
《平价医疗法案》医疗补助扩展对非正式医疗的影响
  • 批准号:
    10351420
  • 财政年份:
    2022
  • 资助金额:
    $ 15.45万
  • 项目类别:
Understanding the impact of the Affordable Care Act on cancer treatment and outcomes for adolescents and young adults (AYA)
了解《平价医疗法案》对青少年和年轻人的癌症治疗和结果的影响 (AYA)
  • 批准号:
    10201216
  • 财政年份:
    2021
  • 资助金额:
    $ 15.45万
  • 项目类别:
Understanding the impact of the Affordable Care Act on healthcare coverage, utilization, and outcomes for childhood cancer survivors
了解《平价医疗法案》对儿童癌症幸存者的医疗保健覆盖范围、利用和结果的影响
  • 批准号:
    10359441
  • 财政年份:
    2021
  • 资助金额:
    $ 15.45万
  • 项目类别:
Understanding the impact of the Affordable Care Act on healthcare coverage, utilization, and outcomes for childhood cancer survivors
了解《平价医疗法案》对儿童癌症幸存者的医疗保健覆盖范围、利用和结果的影响
  • 批准号:
    10533828
  • 财政年份:
    2021
  • 资助金额:
    $ 15.45万
  • 项目类别:
Understanding the impact of the Affordable Care Act on cancer treatment and outcomes for adolescents and young adults (AYA)
了解《平价医疗法案》对青少年和年轻人的癌症治疗和结果的影响 (AYA)
  • 批准号:
    10360535
  • 财政年份:
    2021
  • 资助金额:
    $ 15.45万
  • 项目类别:
The Impact of the Affordable Care Act (ACA) on Unintended Pregnancy: Combining epidemiological and econometric methods.
《平价医疗法案 (ACA)》对意外怀孕的影响:结合流行病学和计量经济学方法。
  • 批准号:
    10254272
  • 财政年份:
    2020
  • 资助金额:
    $ 15.45万
  • 项目类别:
Effects of Affordable Care Act Medicaid Expansion on Disparities in Trauma Care and Outcomes in Young Adults
平价医疗法案医疗补助扩大对年轻人创伤护理和结果差异的影响
  • 批准号:
    9922388
  • 财政年份:
    2019
  • 资助金额:
    $ 15.45万
  • 项目类别:
National estimates of the impact of the affordable care act on healthcare utilization, outcomes and quality among hispanics
《平价医疗法案》对西班牙裔医疗保健利用、结果和质量影响的全国估计
  • 批准号:
    10296663
  • 财政年份:
    2018
  • 资助金额:
    $ 15.45万
  • 项目类别:
National estimates of the impact of the affordable care act on healthcare utilization, outcomes and quality among hispanics
《平价医疗法案》对西班牙裔医疗保健利用、结果和质量影响的全国估计
  • 批准号:
    10063448
  • 财政年份:
    2018
  • 资助金额:
    $ 15.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了